Efficacy of special ultrasonography examination focusing on the pancreas for early detection of pancreatic cancer
Not Applicable
Recruiting
- Conditions
- main pancreatic duct dilatation and/or the presence of pancreatic cysts
- Registration Number
- JPRN-UMIN000041630
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pancreas is not clearly visualized by abdominal ultrasound. 2. Patients who have active or recent malignancies of other organs. 3. Severe comorbidities (such as renal failure, liver failure, heart failure). 4. Difficulty in MRI imaging. 5. Chronic pancreatitis is strongly suspected. 6. Patients who are diagnosed as high-risk stigmata according to the updated 2017 international guidelines on IPMN of the pancreas. 7. Patients who are diagnosed as other pancreatic cystic diseases (such as serious cystic neoplasm and mucinous cystic neoplasm). 8. Pregnant women or women of childbearing potential.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative Incidence of neoplastic progression and the ratio of early detection in patients with neoplastic progression
- Secondary Outcome Measures
Name Time Method Changes of imaging findings and patient characteristics during surveillance, factors associated with early detection of neoplastic progression, The reasons and rates of detailed examinations such as ERCP and EUS-FNA, overall survival time in the patients with neoplastic progression, the rate of recurrence and recurrence-free survival time in the patients who undergo pancreatectomy.